References
- Desai D, Wang J, Wen H, et al. Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms. Pharm Dev Technol 2013;18:1265–1276
- Jamzad S, Fassihi R. Development of a controlled release low dose class II drug-Glipizide. Int J Pharm 2006;312:24–32
- Goole J, Vanderbist F, Amighi K. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int J Pharm 2007;334:35–41
- Vithani K, Cuppok Y, Mostafa S, et al. Diclofenac sodium sustained release hot melt extruded lipid matrices. Pharm Dev Technol 2014;19:531–538
- El-Malah Y, Nazzal S. Effect of Eudragit RS 30D and talc powder on verapamil hydrochloride release from beads coated with drug layered matrices. AAPS PharmSciTech 2008;9:75–83
- Kibria G, Roni MA, Absar MS, Jalil RU. Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D. AAPS PharmSciTech 2008;9:1240–1246
- Körber M, Ciper M, Hoffart V, et al. Enteric polymers as acidifiers for the pH-independent sustained delivery of a weakly basic drug salt from coated pellets. Eur J Pharm Biopharm 2011;78:447–454
- Chakraborty S, Sarkar S, Debnath SK. Formulation development and evaluation of pantoprazole enteric coated tablets. Int J ChemTech 2009;1:663–666
- Diane Bruce L, Koleng JJ, McGinity JW. The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets. Drug Dev Ind Pharm 2003;29:909–924
- He H, Li H, Tang X. Preparation of pH-dependent modified-release pellets of urapidil to improve its bioavailability. Pharm Dev Technol 2011;16:212–218
- Rouge N, Leroux J-C, Cole ET, et al. Prevention of the sticking tendency of floating minitablets filled into hard gelatin capsules. Eur J Pharm Biopharm 1997;43:165–171
- Moës A. Recherche et développement de formes orales à libération contrôlée. J Pharm Belg 1989;44:60–70
- Pawar VK, Kansal S, Garg G, et al. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug Deliv 2011;18:97–110
- Malewar N, Avachat M, Kulkarni S, Pokharkar V. Design and evaluation of novel barrier layer technologies for controlling venlafaxine hydrochloride release from tablet dosage form. Pharm Dev Technol 2014. [Epub ahead of print]. doi: 10.3109/10837450.2014.908303
- Nair AB, Gupta R, Kumria R, et al. Formulation and evaluation of enteric coated tablets of proton pump inhibitor. J Basic Clin Pharm 2010;1:215–221
- Missaghi S, Young C, Fegely K, Rajabi-Siahboomi AR. Delayed release film coating applications on oral solid dosage forms of proton pump inhibitors: case studies. Drug Dev Ind Pharm 2010;36:180–189
- Priese F, Frisch T, Wolf B. Comparison of film-coated retarded release pellets manufactured by layering technique or by bed rotor pelletization. Pharm Dev Technol 2014. [Epub ahead of print]. doi: 10.3109/10837450.2013.879883
- Zheng W, McGinity JW. Influence of Eudragit® NE 30 D blended with Eudragit® L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets. Drug Dev Ind Pharm 2003;29:357–366
- Wesseling M, Kuppler F, Bodmeier R. Tackiness of acrylic and cellulosic polymer films used in the coating of solid dosage forms. Eur J Pharm Biopharm 1999;47:73–78
- Maejima T, McGinity JW. Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers. Pharm Dev Technol 2001;6:211–221
- Prop I. Esomeprazole magnesium. Drugs Future 1999;24:1178–1183
- Richter JE, Kahrilas PJ, Johanson J, et al. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol 2001;96:656–665
- Johnson DA. Review of esomeprazole in the treatment of acid disorders. Expert Opin Pharmcol 2003;4:253–264
- Biswas BK, Islam MS, Begum F, Rouf ASS. In vitro release kinetic study of esomeprazole magnesium from methocel K15M and methocel K100 LVCR matrix tablets. J Pharm Sci 2008;7:39–45
- Sarkar BK, Tanwar SS, Soni P, Jain P. Formulation, characterization and in vitro evaluation of floating microspheres of esomeprazole. Int J Bioassays 2012;1:11–12
- Priese F, Wolf B. Development of high drug loaded pellets by design of experiment and population balance model calculation. Powder Technol 2013;241:149–157
- Kriangkrai W, Puttipipatkhachorn S, Sriamornsak P, et al. Impact of anti-tacking agents on properties of gas-entrapped membrane and effervescent floating tablets. AAPS PharmSciTech 2014;15:1357–1369
- Nimkulrat S, Suchiva K, Phinyocheep P, Puttipipatkhachorn S. Influence of selected surfactants on the tackiness of acrylic polymer films. Int J Pharm 2004;287:27–37
- Erdmann H, Gebert S, Kolter K, Schepky G. Studies on modifying the tackiness and drug release of Kollicoat® EMM 30 D coatings. Drug Dev Ind Pharm 2003;29:429–440
- Kan S-L, Lu J, Liu J-P, Zhao Y. Preparation and in vitro/in vivo evaluation of esomeprazole magnesium-modified release pellets. Drug Deliv 2014. [Epub ahead of print]. doi: 10.3109/10717544.2014.919545
- Maul K, Schmidt P. Influence of different-shaped pigments and plasticizers on theophylline release from Eudragit RS30D and Aquacoat ECD30 coated pellets. STP Pharm Sci 1997;7:498–506
- Schulz R, Williams CR. Commercial talc-animal and mineralogical studies. J Ind Hyg Toxicol 1942;24:75–79
- Parker JW, Peck GE, Banker GS. Effects of solids-loading on moisture permeability coefficients of free films. J Pharm Sci 1974;63:119–125
- Okhamafe AO, York P. Effect of solids-polymer interactions on the properties of some aqueous-based tablet film coating formulations. II. Mechanical characteristics. Int J Pharm 1984;22:273–281
- Nielsen LE. Models for the permeability of filled polymer systems. J Macromol Sci A 1967;1:929–942
- Wang J, Kan S, Chen T, Liu J. Application of quality by design (QbD) to formulation and processing of naproxen pellets by extrusion-spheronization. Pharm Dev Technol 2014;2:246–256
- Sinchaipanid N, Junyaprasert V, Mitrevej A. Application of hot-melt coating for controlled release of propranolol hydrochloride pellets. Powder Technol 2004;141:203–209
- Yang ZY, Lu Y, Tang X. Pseudoephedrine hydrochloride sustained-release pellets prepared by a combination of hot-melt subcoating and polymer coating. Drug Dev Ind Pharm 2008;34:1323–1330
- Chen H, Shi S, Liu A, Tang X. Combined application of extrusion-spheronization and hot-melt coating technologies for improving moisture-proofing of herbal extracts. J Pharm Sci 2010;99:2444–2454